Drugs / DSP-8658
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01042106 | Nov 2009 → Jul 2010 | type 2 diabetes mellitus | Sumitomo Pharma America, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DSP-8658 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01042106 ↗ |
| Route | Oral | “DSP-8658 - 2.5, 10, 20, 40 mg orally once daily” NCT01042106 ↗ |